These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


454 related items for PubMed ID: 16421922

  • 1. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma.
    Chen PY, Vicini FA, Benitez P, Kestin LL, Wallace M, Mitchell C, Pettinga J, Martinez AA.
    Cancer; 2006 Mar 01; 106(5):991-9. PubMed ID: 16421922
    [Abstract] [Full Text] [Related]

  • 2. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
    Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A.
    Am J Surg; 2004 Oct 01; 188(4):355-64. PubMed ID: 15474426
    [Abstract] [Full Text] [Related]

  • 3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):489-95. PubMed ID: 16246495
    [Abstract] [Full Text] [Related]

  • 4. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR, Keisch ME, Vicini F, Stolier A, Scroggins T, Walker A, White J, Hedberg P, Hebert M, Arthur D, Zannis V, Quiet C, Streeter O, Silverstein M.
    Am J Surg; 2007 Oct 01; 194(4):456-62. PubMed ID: 17826055
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR, Winter K, Arthur DW, Bolton J, Rabinovitch R, White J, Hanson W, Wilenzick RM.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):45-51. PubMed ID: 16503383
    [Abstract] [Full Text] [Related]

  • 6. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M, Martinez A, Mitchell C, Chen PY, Ghilezan M, Benitez P, Brown E, Vicini F.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):531-6. PubMed ID: 19775830
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):32-40. PubMed ID: 17467920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
    Goyal S, Khan AJ, Vicini F, Beitsch PD, Lyden M, Keisch M, Haffty BG.
    Ann Surg Oncol; 2009 Sep 01; 16(9):2450-8. PubMed ID: 19517191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer.
    Richards GM, Berson AM, Rescigno J, Sanghavi S, Siegel B, Axelrod D, Bernik S, Scarpinato V, Mills C.
    Ann Surg Oncol; 2004 Aug 01; 11(8):739-46. PubMed ID: 15249336
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.